Universe Pharmaceuticals Inc (UPC) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Universe Pharmaceuticals Inc  (NASDAQ: UPC)


Universe Pharmaceuticals Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Universe Pharmaceuticals Inc's ROI in the fourth quarter of 2025?
Universe Pharmaceuticals Inc had a negative return on investment (ROI) of -6.36%, due to the net loss of $-3 billion, during the twelve months ending in the fourth quarter of 2025.

Within the Healthcare sector 258 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 2970.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2023)
IV. Quarter
Y / Y Investment Change TTM 205.19 % 692.36 % 469.21 % 269.49 % 113.4 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 56,130 62,580 56,130 56,130 47,640
Return On Investment (TTM) -6.36 % -0.01 % -0.02 % -0.02 % -0.03 %
UPC's Overall Ranking # 2970 # # # #
Seq. Investment Change TTM 3.82 % 39.11 % 54.02 % 37.21 % 169.53 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -3,672 -6 -6 -6 -6

UPC Company Profile >> Back to UPC Roi Comparisons >> See Annual UPC Return On Investment



Return On Investment UPC's Ranking
Within: No.
Industry # 87
Sector # 259
Overall # 2970

Return On Investment Statistics
High Average Low
19.21 %
-5.39 %
-18.81 %
(Sep 30 2021)   (Sep 30 2022)







Financial Statements
Universe Pharmaceuticals Inc's IV. Quarter Investments $ 56,130 Millions UPC's Balance sheet
Universe Pharmaceuticals Inc's IV. Quarter Income $ -3,672 Millions Quarterly UPC's Income Statement
UPC's Income by Division See UPC's Income by Division


UPC Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021
Total Investments in Millions 56,130 47,640 27,970 35,331 47
Y / Y Investment Growth 17.82 % 70.33 % -20.83 % 75083.59 % -
Net Income in Millions -3,672 -8,727 -6 -9 11
Y / Y Net Income Growth - - - - -
Annual Return On Investment -6.54 % -18.32 % -0.02 % -0.02 % 24.09 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
UPC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for UPC's Competitors
Subscribers only: Roi for Universe Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for UPC's Customers

Other Ratios
UPC's Roa UPC's Inventory Turnover Ratio UPC's Growth Rates UPC's Dividend Statistics
UPC's Profitability Ratios UPC's Asset Turnover Ratio UPC's Dividend Growth
UPC's Roe UPC's Valuation Ratios UPC's Financial Strength Ratios UPC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI

Date modified: 2026-07-07T13:48:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.